News
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.
A bipartisan group of U.S. lawmakers, including several prominent members from Florida, has sent a pointed letter to FDA ...
Comedian and Emmy-nominated actor Kym Whitley opens up about her long journey with weight management. The "Happy Gilmore 2" ...
A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...
Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...
Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...
B.C. is a great place to work, play, raise a family, and be with loved ones. But like many other places in the world, we’ve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results